A5053410251- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- COVID-19 Clinical Research Studies
- Mental Health and Patient Involvement
- Adolescent and Pediatric Healthcare
- COVID-19 epidemiological studies
- Intensive Care Unit Cognitive Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Respiratory viral infections research
- Multiple Sclerosis Research Studies
- SARS-CoV-2 and COVID-19 Research
- Ethics in Clinical Research
- Health Policy Implementation Science
- Healthcare Systems and Challenges
- Social Media in Health Education
- Employment and Welfare Studies
- Global Health Care Issues
- Empathy and Medical Education
- Congenital Diaphragmatic Hernia Studies
- Patient-Provider Communication in Healthcare
- Healthcare Policy and Management
- Geriatric Care and Nursing Homes
- Vaccine Coverage and Hesitancy
- Neonatal Respiratory Health Research
- Hepatitis C virus research
Pfizer (United Kingdom)
2022-2025
Pfizer (United States)
2023-2024
This study aimed to (1) gauge patients understanding and expectations of real-world data evidence (RWDE) research (2) use this lived experience co-create resources a framework for embedding meaningful patient public involvement engagement (PPIE) in RWDE within the pharmaceutical industry setting. An academic organisation, company PPIE panel 12 or carers partnered form project team. The was purposively selected maximise diversity. Participatory co-design methods were used engender an...
Objectives To estimate the impact of COVID-19 infection on requirement for social care services among adults aged >=50 years in North-West London. Design Population based matched cohort study using linked routinely collected electronic care, primary and hospital records (the Discover dataset). Setting Approximately 4.7 million people with a general practitioner record Participants 150,654 first diagnosis between January 2020 February 2023 547,704 propensity score comparators without...
Long COVID, a diverse set of symptoms that persist after minimum 4 weeks from the initial SARS-CoV-2 infection, has posed substantial burden to healthcare systems. There is some evidence COVID-19 vaccination may be associated with lower risk long COVID. However, little known about association between status and COVID-associated resource utilisation (HCRU) costs. We conducted cohort study using primary care electronic health record data in England Clinical Practice Research Datalink (CPRD)...
To quantify direct costs and healthcare resource utilisation (HCRU) associated with acute COVID-19 in adults England.
Background Updating vaccines is essential for combatting emerging coronavirus disease 2019 (COVID-19) variants. This study assessed the public health and economic impact of a booster dose an adapted vaccine in United Kingdom (UK).
The delivery of COVID-19 vaccines was successful in reducing hospitalizations and mortality. However, emergence the Omicron variant resulted increased virus transmissibility. Consequently, booster vaccination programs were initiated to decrease risk severe disease death among vulnerable members population. This study aimed estimate effects program alternative strategies on morbidity mortality due UK. A Susceptible-Exposed-Infectious-Recovered (SEIR) model used assess impact several outcomes...
ABSTRACT Objectives To quantify healthcare resource utilisation (HCRU) and costs to the National Health Service (NHS) associated with acute COVID-19 in adults England. Design Population-based retrospective cohort study, using Clinical Practice Research Datalink (CPRD) Aurum primary care electronic medical records linked when available Hospital Episode Statistics (HES) secondary administrative data. Setting Patients registered practices Population 1,706,368 a positive SARS-CoV-2 PCR or...
ABSTRACT Background Long COVID, a diverse set of symptoms that persist after minimum 4 weeks from the initial SARS-CoV-2 infection, has posed substantial burden to healthcare systems. There is some evidence COVID-19 vaccination may be associated with lower risk long COVID. However, little known about association between status and COVID-associated resource utilisation (HCRU) costs. Methods We conducted cohort study using primary care electronic health record data in England Clinical Practice...
ABSTRACT Background Although COVID-19 morbidity is significantly lower in pediatrics than adults, the risk of severe may still pose substantial healthcare resource burden. This study aimed to describe utilization (HCRU) and costs associated with aged 1-17 years England. Methods A population-based retrospective cohort using Clinical Practice Research Datalink (CPRD Aurum) primary care data and, where available, linked Hospital Episode Statistics Admitted Patient Care (HES APC) secondary data....
<b>Introduction:</b> National estimates of hospitalisation costs in medically attended Respiratory Syncytial Virus (RSV) infections are necessary to elucidate economic burden and inform immunisation policies. Current published hospitalization for RSV among paediatric patients underestimate the true by omitting incurred critically ill number Finished Consultation Episodes (FCE). <b>Aim:</b> To estimate 2020/21 mean cost per admission infants < 12 months hospitalized with RSV, from...
Background: Although COVID-19 morbidity is significantly lower in pediatrics than adults, the risk of severe may still pose substantial health care resource burden. This study aimed to describe utilization (HCRU) and costs associated with 1–17 years old England. Methods: A population-based retrospective cohort using Clinical Practice Research Datalink (CPRD Aurum) primary data and, where available, linked Hospital Episode Statistics Admitted Patient Care secondary data. HCRU National Health...